dc.contributor.author |
Tshweu, L
|
|
dc.contributor.author |
Katata, L
|
|
dc.contributor.author |
Naidoo, Saloshnee
|
|
dc.contributor.author |
Kalombo, Lonji
|
|
dc.contributor.author |
Swai, H
|
|
dc.date.accessioned |
2012-11-01T06:46:21Z |
|
dc.date.available |
2012-11-01T06:46:21Z |
|
dc.date.issued |
2012-10 |
|
dc.identifier.citation |
Tshweu, L., Katata, L., Naidoo, S., Kalombo, L. and Swai, H. Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters. 4th CSIR Biennial Conference: Real problems relevant solutions, CSIR, Pretoria, 9-10 October 2012 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10204/6262
|
|
dc.description |
4th CSIR Biennial Conference: Real problems relevant solutions, CSIR, Pretoria, 9-10 October 2012 |
en_US |
dc.description.abstract |
AIDS kills over 1.5 million people a year globally. Current HIV drugs pose many challenges. This presentation shows that nano-encapsulation of HIV drugs achieves controlled and steady drug release, and
reduced dosing frequency. |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
AIDS |
en_US |
dc.subject |
HIV |
en_US |
dc.subject |
anti-HIV drugs |
en_US |
dc.subject |
Nano-encapsulation |
en_US |
dc.subject |
Dosing frequency |
en_US |
dc.title |
Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters |
en_US |
dc.type |
Conference Presentation |
en_US |
dc.identifier.apacitation |
Tshweu, L., Katata, L., Naidoo, S., Kalombo, L., & Swai, H. (2012). Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters. http://hdl.handle.net/10204/6262 |
en_ZA |
dc.identifier.chicagocitation |
Tshweu, L, L Katata, Saloshnee Naidoo, Lonji Kalombo, and H Swai. "Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters." (2012): http://hdl.handle.net/10204/6262 |
en_ZA |
dc.identifier.vancouvercitation |
Tshweu L, Katata L, Naidoo S, Kalombo L, Swai H, Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters; 2012. http://hdl.handle.net/10204/6262 . |
en_ZA |
dc.identifier.ris |
TY - Conference Presentation
AU - Tshweu, L
AU - Katata, L
AU - Naidoo, Saloshnee
AU - Kalombo, Lonji
AU - Swai, H
AB - AIDS kills over 1.5 million people a year globally. Current HIV drugs pose many challenges. This presentation shows that nano-encapsulation of HIV drugs achieves controlled and steady drug release, and
reduced dosing frequency.
DA - 2012-10
DB - ResearchSpace
DP - CSIR
KW - AIDS
KW - HIV
KW - anti-HIV drugs
KW - Nano-encapsulation
KW - Dosing frequency
LK - https://researchspace.csir.co.za
PY - 2012
T1 - Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters
TI - Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters
UR - http://hdl.handle.net/10204/6262
ER -
|
en_ZA |